Lajolla Institute For Allergy And Immunology competitive analysis

Loading summary...

Explore Lajolla Institute For Allergy And Immunology's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 19, 2020Light Inhibitors For Asthma, Lung And Airway Inflammation, Respiratory, Interstitial, Pulmonary And Fibrotic Disease Treatment1

Latest publications and patents of Lajolla Institute For Allergy And Immunology New

Explore the latest publications and patents granted to Lajolla Institute For Allergy And Immunology, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Lajolla Institute For Allergy And Immunology

Feb 19, 2020Light Inhibitors For Asthma, Lung And Airway Inflammation, Respiratory, Interstitial, Pulmonary And Fibrotic Disease TreatmentRevoked

Latest PTAB cases involving Lajolla Institute For Allergy And Immunology

Discover the latest PTAB cases involving Lajolla Institute For Allergy And Immunology, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Lajolla Institute For Allergy And Immunology with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LAJOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY - 1 - -
EUROPEAN OPPOSITIONS30 - - -